Glaxosmithkline Uk Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Glaxosmithkline Uk Limited

Patent Number:
Title:
Medicaments For Increasing Endogenous Erythropoietine (Epo)
Applicant:
Opposition Date:
Feb 19, 2020
Patent Number:
Title:
Use Of Hif Alpha Stabilizers For Enhancing Erythropoiesis
Applicant:
Opposition Date:
Jun 26, 2019

Competitors of Glaxosmithkline Uk Limited

FIBROGEN, INC.

Want to track Glaxosmithkline Uk Limited?

Feel free to send us a message here and we will get back to you